DRUGS
Scale from 0 to 100
Revised Cardiac Risk Index for Pre‑Operative Risk: Estimates risk of major cardiac complications after noncardiac surgery.
DRUGS: Insulin lowers blood glucose by increasing peripheral glucose uptake.
Indications for Use
Used to stratify perioperative MACE risk in adults undergoing non‑cardiac surgery, especially elective or time‑sensitive procedures. Helps identify patients with elevated cardiac risk (RCRI >1 ≈ ≥1% MACE) to guide decisions on need for further testing, optimization of medical therapy, and perioperative planning (2024 AHA/ACC guideline 1). Not reliable for vascular or emergent surgery.
Insights & Cautions
Continue chronic beta‑blockers and avoid new initiation within 7 days; never start on day of surgery due to harm 1 [Level I evidence]. Hold SGLT2 inhibitors 3–4 days pre‑op to prevent ketoacidosis 2 [Level I evidence]. Withhold ACEi/ARB 24 hours pre‑op in hypertension to reduce intraoperative hypotension 3 [Level I evidence]. Avoid initiating clonidine; continuation only. Manage antiplatelets/anticoagulants per procedural bleeding/thrombotic risk.